Background Patients' adherence to prescribed Artemisinin-based Combination Therapy
(ACT) treatment is a key malaria control strategy. To accelerate and realize a malaria free …

Background: Nigeria adopted the Artemisinin-Based Combination Therapy (ACT) as the
mainstay of treating uncomplicated malaria in February 2005. However, the individual …

Background Transmission-blocking vaccine (TBV) is a promising strategy for interrupting the
malaria transmission cycle. Current TBV candidates include both pre-and post-fertilization …

Globally, malaria continues to have clinical importance and economic impact. There is
insufficient data on direct medical costs of malaria treatment at healthcare facilities since the …

Background Under-five malaria in Nigeria remains one of the biggest threats to global child
health, accounting for 95,000 annual child deaths. Despite having the highest GDP in Africa …

Objective: To synthesize orally bioavailable artemisinin dimers and the evaluation of their in
vivo antimalarial activity. Methods: Artemsisin dimers were synthesized and their …

After decades of successful artemisinin regimen in combating malaria, its effectiveness has
decreased since parasite resistance to the treatment regimen has begun to appear …

Since 2005, the recommended first-line therapy for uncomplicated malaria in Nigeria has
been Artemisinin-based Combination Therapy (ACT). Previous research indicates that these …

Background Global malaria control programmes such as approaches to community
engagements to deliver malaria control interventions have been successful in controlling …

With over 100 million cases of morbidity annually worldwide; control, elimination and
eradication of malaria still remains a major challenge, particularly in sub-Saharan Africa. In …